[Skip to Navigation]
Sign In
November 19, 2020

Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy

Author Affiliations
  • 1Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
  • 2Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
  • 3George Institute for Global Health, University of New South Wales, Sydney, Australia
JAMA. 2020;324(22):2259-2260. doi:10.1001/jama.2020.21395
Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Polypil in HFrEF
    Vladimir Baksheev, MD, PhD | FSBI Cvkg named A.A. Vishnevskii
    Simplifications are not always reliable, but in the case of patients with chronic disease, polypills are justified and may be successful.